Literature DB >> 26319443

Implantable loop recorder monitoring after concomitant surgical ablation for atrial fibrillation (AF): insights from more than 200 continuously monitored patients.

Simon Pecha1, Muhammet Ali Aydin2, Teymour Ahmadzade3, Friederike Hartel4, Boris Hoffmann4, Daniel Steven5, Stephan Willems4, Hermann Reichenspurner3, Florian Mathias Wagner3.   

Abstract

Different follow-up methods have been used to report success rates after AF ablation. Recent studies have shown that intermittent rhythm monitoring underestimates the actual AF recurrence rate. We therefore report our experience with continuous rhythm monitoring by implantable loop recorder (ILR) in a large patient cohort. Between 09/2008 and 12/2012, 343 cardiac surgical patients underwent concomitant surgical AF ablation. ILR implantation was performed in 206 patients. ILR interrogation was accomplished at 3, 6 and 12 months postoperatively. Successful ablation was defined as AF Burden <0.5 %. Primary outcome of the study was freedom from AF at 12-month follow-up. Mean patient's age was 70.5 ± 7.4 years. No major ablation- or ILR-related complications occurred. In 4 patients (1.9 %) ILR had to be explanted due to ILR-related wound infection (n = 2) or chronic pain (n = 2). Survival rate at 1-year follow-up was 96.6 %. Freedom from AF rate after 1-year follow-up was 68.5 and 63.6 % off antiarrhythmic drugs, respectively. Statistically significant predictors for successful ablation at 1-year follow-up were smaller LA diameter, shorter duration of AF and preoperative paroxysmal AF. Demographic data, indication for surgery, lesion set and used energy source had no impact on freedom from AF after 1 year. Continuous ILR monitoring after concomitant surgical AF ablation was safe and feasible, with registered freedom from AF rate of 68.5 % at 1-year follow-up. Thus continuous rhythm monitoring provides reliable outcome data and helps to guide antiarrhythmic therapy.

Entities:  

Keywords:  Arrhythmia surgery; Atrial fibrillation; Implantable loop recorder monitoring; Surgical ablation of atrial fibrillation

Mesh:

Year:  2015        PMID: 26319443     DOI: 10.1007/s00380-015-0735-4

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  23 in total

1.  Efficacy of an additional MAZE procedure using cooled-tip radiofrequency ablation in patients with chronic atrial fibrillation and mitral valve disease. A randomized, prospective trial.

Authors:  T Deneke; K Khargi; P H Grewe; A Laczkovics; S von Dryander; T Lawo; K-M Müller; B Lemke
Journal:  Eur Heart J       Date:  2002-04       Impact factor: 29.983

2.  Executive summary: heart disease and stroke statistics--2010 update: a report from the American Heart Association.

Authors:  Donald Lloyd-Jones; Robert J Adams; Todd M Brown; Mercedes Carnethon; Shifan Dai; Giovanni De Simone; T Bruce Ferguson; Earl Ford; Karen Furie; Cathleen Gillespie; Alan Go; Kurt Greenlund; Nancy Haase; Susan Hailpern; P Michael Ho; Virginia Howard; Brett Kissela; Steven Kittner; Daniel Lackland; Lynda Lisabeth; Ariane Marelli; Mary M McDermott; James Meigs; Dariush Mozaffarian; Michael Mussolino; Graham Nichol; Véronique L Roger; Wayne Rosamond; Ralph Sacco; Paul Sorlie; Randall Stafford; Thomas Thom; Sylvia Wasserthiel-Smoller; Nathan D Wong; Judith Wylie-Rosett
Journal:  Circulation       Date:  2010-02-23       Impact factor: 29.690

3.  Incidence and predictors of pacemaker placement after surgical ablation for atrial fibrillation.

Authors:  Berhane Worku; Sang-Woo Pak; Faisal Cheema; Mark Russo; Brian Housman; Danielle Van Patten; Jessica Harris; Michael Argenziano
Journal:  Ann Thorac Surg       Date:  2011-12       Impact factor: 4.330

4.  A comprehensive evaluation of rhythm monitoring strategies for the detection of atrial fibrillation recurrence: insights from 647 continuously monitored patients and implications for monitoring after therapeutic interventions.

Authors:  Efstratios I Charitos; Ulrich Stierle; Paul D Ziegler; Malte Baldewig; Derek R Robinson; Hans-Hinrich Sievers; Thorsten Hanke
Journal:  Circulation       Date:  2012-07-23       Impact factor: 29.690

5.  Surgical ablation as treatment for the elimination of atrial fibrillation: a meta-analysis.

Authors:  Scott D Barnett; Niv Ad
Journal:  J Thorac Cardiovasc Surg       Date:  2006-05       Impact factor: 5.209

6.  Long-term results of the maze procedure on left ventricular function for persistent atrial fibrillation associated with mitral valve disease.

Authors:  Yujiro Fukuda; Teruhisa Yoshida; Tomohito Inage; Tomohiro Takeuchi; Takeki Gondo; Eiichi Takii; Tsutomu Imaizumi
Journal:  Heart Vessels       Date:  2011-02-18       Impact factor: 2.037

7.  Efficacy and safety of novel epicardial circumferential left atrial ablation with pulmonary vein isolation in sustained atrial fibrillation.

Authors:  Zhaolei Jiang; Hang Yin; Yi He; Nan Ma; Min Tang; Hao Liu; Fangbao Ding; Ju Mei
Journal:  Heart Vessels       Date:  2014-10-17       Impact factor: 2.037

8.  :Influence of the duration of Holter monitoring on the detection of arrhythmia recurrences after catheter ablation of atrial fibrillation: implications for patient follow-up.

Authors:  Nikolaos Dagres; Hans Kottkamp; Christopher Piorkowski; Sebastian Weis; Arash Arya; Philipp Sommer; Kerstin Bode; Jin-Hong Gerds-Li; Dimitrios Th Kremastinos; Gerhard Hindricks
Journal:  Int J Cardiol       Date:  2008-11-05       Impact factor: 4.164

9.  Surgical treatment of permanent atrial fibrillation using microwave energy ablation: a prospective randomized clinical trial.

Authors:  A Schuetz; C J Schulze; K K Sarvanakis; H Mair; H Plazer; E Kilger; B Reichart; S M Wildhirt
Journal:  Eur J Cardiothorac Surg       Date:  2003-10       Impact factor: 4.191

10.  Event recorder monitoring to compare the efficacy of a left versus biatrial lesion set in patients undergoing concomitant surgical ablation for atrial fibrillation.

Authors:  Simon Pecha; Friederike Hartel; Teymour Ahmadzade; Muhammet Ali Aydin; Stephan Willems; Hermann Reichenspurner; Florian Mathias Wagner
Journal:  J Thorac Cardiovasc Surg       Date:  2014-02-26       Impact factor: 5.209

View more
  8 in total

1.  2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation.

Authors:  Hugh Calkins; Gerhard Hindricks; Riccardo Cappato; Young-Hoon Kim; Eduardo B Saad; Luis Aguinaga; Joseph G Akar; Vinay Badhwar; Josep Brugada; John Camm; Peng-Sheng Chen; Shih-Ann Chen; Mina K Chung; Jens Cosedis Nielsen; Anne B Curtis; D Wyn Davies; John D Day; André d'Avila; N M S Natasja de Groot; Luigi Di Biase; Mattias Duytschaever; James R Edgerton; Kenneth A Ellenbogen; Patrick T Ellinor; Sabine Ernst; Guilherme Fenelon; Edward P Gerstenfeld; David E Haines; Michel Haissaguerre; Robert H Helm; Elaine Hylek; Warren M Jackman; Jose Jalife; Jonathan M Kalman; Josef Kautzner; Hans Kottkamp; Karl Heinz Kuck; Koichiro Kumagai; Richard Lee; Thorsten Lewalter; Bruce D Lindsay; Laurent Macle; Moussa Mansour; Francis E Marchlinski; Gregory F Michaud; Hiroshi Nakagawa; Andrea Natale; Stanley Nattel; Ken Okumura; Douglas Packer; Evgeny Pokushalov; Matthew R Reynolds; Prashanthan Sanders; Mauricio Scanavacca; Richard Schilling; Claudio Tondo; Hsuan-Ming Tsao; Atul Verma; David J Wilber; Teiichi Yamane
Journal:  Heart Rhythm       Date:  2017-05-12       Impact factor: 6.343

Review 2.  [Implantable loop recorder in atrial fibrillation and after catheter ablation].

Authors:  K Fikenzer; N Dagres; G Hindricks
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2016-11-10

3.  2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: a report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Endorsed by the governing bodies of the American College of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia Pacific Heart Rhythm Society, and the Heart Rhythm Society.

Authors:  Hugh Calkins; Karl Heinz Kuck; Riccardo Cappato; Josep Brugada; A John Camm; Shih-Ann Chen; Harry J G Crijns; Ralph J Damiano; D Wyn Davies; John DiMarco; James Edgerton; Kenneth Ellenbogen; Michael D Ezekowitz; David E Haines; Michel Haissaguerre; Gerhard Hindricks; Yoshito Iesaka; Warren Jackman; José Jalife; Pierre Jais; Jonathan Kalman; David Keane; Young-Hoon Kim; Paulus Kirchhof; George Klein; Hans Kottkamp; Koichiro Kumagai; Bruce D Lindsay; Moussa Mansour; Francis E Marchlinski; Patrick M McCarthy; J Lluis Mont; Fred Morady; Koonlawee Nademanee; Hiroshi Nakagawa; Andrea Natale; Stanley Nattel; Douglas L Packer; Carlo Pappone; Eric Prystowsky; Antonio Raviele; Vivek Reddy; Jeremy N Ruskin; Richard J Shemin; Hsuan-Ming Tsao; David Wilber
Journal:  Heart Rhythm       Date:  2012-03-01       Impact factor: 6.343

Review 4.  2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation.

Authors:  Hugh Calkins; Gerhard Hindricks; Riccardo Cappato; Young-Hoon Kim; Eduardo B Saad; Luis Aguinaga; Joseph G Akar; Vinay Badhwar; Josep Brugada; John Camm; Peng-Sheng Chen; Shih-Ann Chen; Mina K Chung; Jens Cosedis Nielsen; Anne B Curtis; D Wyn Davies; John D Day; André d'Avila; N M S Natasja de Groot; Luigi Di Biase; Mattias Duytschaever; James R Edgerton; Kenneth A Ellenbogen; Patrick T Ellinor; Sabine Ernst; Guilherme Fenelon; Edward P Gerstenfeld; David E Haines; Michel Haissaguerre; Robert H Helm; Elaine Hylek; Warren M Jackman; Jose Jalife; Jonathan M Kalman; Josef Kautzner; Hans Kottkamp; Karl Heinz Kuck; Koichiro Kumagai; Richard Lee; Thorsten Lewalter; Bruce D Lindsay; Laurent Macle; Moussa Mansour; Francis E Marchlinski; Gregory F Michaud; Hiroshi Nakagawa; Andrea Natale; Stanley Nattel; Ken Okumura; Douglas Packer; Evgeny Pokushalov; Matthew R Reynolds; Prashanthan Sanders; Mauricio Scanavacca; Richard Schilling; Claudio Tondo; Hsuan-Ming Tsao; Atul Verma; David J Wilber; Teiichi Yamane
Journal:  Europace       Date:  2018-01-01       Impact factor: 5.214

5.  Clinical outcomes of AF patients treated with the first and second-generation of circular mapping and ablation catheter: insights from a real world multicenter experience.

Authors:  Giovanni Rovaris; Paolo De Filippo; Francesco Laurenzi; Gabriele Zanotto; Nicola Bottoni; Mattia Pozzi; Fabrizio Giofrè; Piergiuseppe De Girolamo; Emanuela Visentin; Elena Piazzi; Paola Ferrari
Journal:  J Interv Card Electrophysiol       Date:  2017-09-05       Impact factor: 1.900

6.  Assessment of atrial fibrillation ablation outcomes with clinic ECG, monthly 24-h Holter ECG, and twice-daily telemonitoring ECG.

Authors:  Takehiro Kimura; Yoshiyasu Aizawa; Naomi Kurata; Kazuaki Nakajima; Shin Kashimura; Akira Kunitomi; Takahiko Nishiyama; Yoshinori Katsumata; Nobuhiro Nishiyama; Kotaro Fukumoto; Yoko Tanimoto; Keiichi Fukuda; Seiji Takatsuki
Journal:  Heart Vessels       Date:  2016-07-06       Impact factor: 2.037

7.  Use of antiarrhythmic drugs during ablation of persistent atrial fibrillation: observations from a large single-centre cohort.

Authors:  Jakob Lüker; Arian Sultan; Susanne Sehner; Boris Hoffmann; Helge Servatius; Stephan Willems; Daniel Steven
Journal:  Heart Vessels       Date:  2015-11-06       Impact factor: 2.037

8.  The BIOMONITOR III Injectable Cardiac Monitor: Clinical Experience with a Novel Injectable Cardiac Monitor.

Authors:  Nico Reinsch; Anna Füting; Dennis Höwel; Kars Neven
Journal:  J Clin Med       Date:  2022-03-16       Impact factor: 4.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.